SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION Pharmaceutical Investing
Health Canada Approves KEYTRUDA® as monotherapy for the adjuvant treatment of adults with renal cell carcinoma at intermediate-high or high risk of recurrence following nephrectomy or following nephrectomy and resection of metastatic lesions Life Science Investing
GreenLight Biosciences announces realignment to focus on near-term value drivers Life Science Investing
Silo Wellness Adds Biotech Research Expertise to its Psychedelic Wellness Portfolio Psychedelics Investing
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Gilead's Trodelvy® for Pre-Treated HR+/HER2- Metastatic Breast Cancer Pharmaceutical Investing
Ginkgo Bioworks Announces Collaboration with Merck to Improve Active Pharmaceutical Ingredient Manufacturing Life Science Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
